Execution is my main concern. While we anticipate

Execution is my main concern. While we anticipate that the FDA will finally grant approval and hopefully with orphan drug status, my main concern is the execution going forward. I don't believe those running BMSN have any track record of taking a drug trough the clinical trial process. The success of good management is crucial. Do we know that BMSN's management (Koos et cet) really know what they are doing? I figure we will soon find out.